Kras
Bartlomiej Stefan Kras, Piastow PL
| Patent application number | Description | Published |
|---|---|---|
| 20110244300 | THERMO-STABILIZED ELECTRIC BATTERY MODULE - Electric cells ( | 10-06-2011 |
Eva Kras, Seattle, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20080311078 | Self-Buffering Protein Formulations - The invention herein described, provides, among other things, self-buffering protein formulations. Particularly, the invention provides self-buffering pharmaceutical protein formulations that are suitable for veterinary and human medical use. The self-buffering protein formulations are substantially free of other buffering agents, stably maintain pH for the extended time periods involved in the distribution and storage of pharmaceutical proteins for veterinary and human medical use. The invention further provides methods for designing, making, and using the formulation. In addition to other advantages, the formulations avoid the disadvantages associated with the buffering agents conventionally used in current formulations of proteins for pharmaceutical use. The invention in these and other respects can be productively applied to a wide variety of proteins and is particularly useful for making and using self-buffering formulations of pharmaceutical proteins for veterinary and medical use, especially, in particular, for the treatment of diseases in human subjects. | 12-18-2008 |
Eva Kras, Redmond, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20120028877 | Self-Buffering Protein Formulations - The invention herein described, provides, among other things, self-buffering protein formulations. Particularly, the invention provides self-buffering pharmaceutical protein formulations that are suitable for veterinary and human medical use. The self-buffering protein formulations are substantially free of other buffering agents, stably maintain pH for the extended time periods involved in the distribution and storage of pharmaceutical proteins for veterinary and human medical use. The invention further provides methods for designing, making, and using the formulation. In addition to other advantages, the formulations avoid the disadvantages associated with the buffering agents conventionally used in current formulations of proteins for pharmaceutical use. The invention in these and other respects can be productively applied to a wide variety of proteins and is particularly useful for making and using self-buffering formulations of pharmaceutical proteins for veterinary and medical use, especially, in particular, for the treatment of diseases in human subjects. | 02-02-2012 |
| 20130273066 | Self-Buffering Protein Formulations - The invention herein described, provides, among other things, self-buffering protein formulations. Particularly, the invention provides self-buffering pharmaceutical protein formulations that are suitable for veterinary and human medical use. The self-buffering protein formulations are substantially free of other buffering agents, stably maintain pH for the extended time periods involved in the distribution and storage of pharmaceutical proteins for veterinary and human medical use. The invention further provides methods for designing, making, and using the formulation. In addition to other advantages, the formulations avoid the disadvantages associated with the buffering agents conventionally used in current formulations of proteins for pharmaceutical use. The invention in these and other respects can be productively applied to a wide variety of proteins and is particularly useful for making and using self-buffering formulations of pharmaceutical proteins for veterinary and medical use, especially, in particular, for the treatment of diseases in human subjects. | 10-17-2013 |
| 20130273067 | Self-Buffering Protein Formulations - The invention herein described, provides, among other things, self-buffering protein formulations. Particularly, the invention provides self-buffering pharmaceutical protein formulations that are suitable for veterinary and human medical use. The self-buffering protein formulations are substantially free of other buffering agents, stably maintain pH for the extended time periods involved in the distribution and storage of pharmaceutical proteins for veterinary and human medical use. The invention further provides methods for designing, making, and using the formulation. In addition to other advantages, the formulations avoid the disadvantages associated with the buffering agents conventionally used in current formulations of proteins for pharmaceutical use. The invention in these and other respects can be productively applied to a wide variety of proteins and is particularly useful for making and using self-buffering formulations of pharmaceutical proteins for veterinary and medical use, especially, in particular, for the treatment of diseases in human subjects. | 10-17-2013 |
Stephen J. Kras, Chicago, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080272514 | Closure Cap With Injection Molded Annular Gasket and Method of Making Same - A closure cap and method of making the same wherein an annular or ring-shaped gasket is injection molded onto the inner surface of a cap shell formed of plastic or metal. The annular or ring-shaped gasket includes radially extending tabs integrally formed therewith, one of said tabs being formed at a location wherein the plastic melt is fed to an annular gasket-forming channel in a mold core and another of said tabs being formed at the location wherein plastic melt is discharged from said channel. Preferably, said other tab includes a cold well formation which communicates with the annular gasket through a connecting portion of reduced cross-sectional area with respect to the cross-sectional areas of both the gasket and the cold well formation. | 11-06-2008 |
| 20140263155 | METAL CLOSURE AND SEAL COMBINATION FOR MAINTAINING THE SHAPE OF A PLASTIC CONTAINER NECK - A closure that includes a top panel and a skirt extending downwardly from a peripheral edge of the top panel is provided. The skirt terminates in a plurality of spaced thread engagement flanges for engaging the thread of the neck of a container. The closure includes a polymer-filled channel which connects the top panel to the skirt. When engaged with the threaded neck of a container, the neck is forced into the channel and engaged by the polymer so that the channel and polymer provide lateral rigidity to the neck. This rigidity prevents the neck from deflecting from the forces resulting between the threads and thread engagement lugs when the forces therebetween are increased to the level required to adequately seal the closure to the container. | 09-18-2014 |
| 20150041474 | METAL CLOSURE AND SEAL COMBINATION FOR MAINTAINING THE SHAPE OF A PLASTIC CONTAINER NECK - A closure that includes a top panel and a skirt extending downwardly from a peripheral edge of the top panel is provided. The skirt terminates in a plurality of spaced thread engagement flanges for engaging the thread of the neck of a container. The closure includes a polymer-filled channel which connects the top panel to the skirt. When engaged with the threaded neck of a container, the neck is forced into the channel and engaged by the polymer so that the channel and polymer provide lateral rigidity to the neck. This rigidity prevents the neck from deflecting from the forces resulting between the threads and thread engagement lugs when the forces therebetween are increased to the level required to adequately seal the closure to the container. | 02-12-2015 |